Tema Heart & Health ETF Rating $28.66 -0.01 (-0.03%) As of 10:45 AM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Tema Heart & Health ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HRTS Aggregate RatingModerate Buy 2.76Holdings in HRTS have an aggregate rating of Moderate Buy based on 1,284 analyst ratings issued in the past year covering 78 companies (159.3% of the portfolio).HRTS Aggregate Price Target$28.66High Prediction$28.66Average Prediction$28.66Low Prediction$28.66Holdings in HRTS have an aggregate price target of $28.66 and a range of $28.66 to $28.66 covering 78 companies (159.3% of the portfolio).HRTS Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy20 Buy rating(s)Moderate Buy48 Moderate Buy rating(s)Hold10 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Heart & Health ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 78 HRTS Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.71%LLYEli Lilly and Company$779.60+0.0%4.9889 of 5 stars2.75$1,011.61 29.8%20Positive News9.71%LLYEli Lilly and Company$779.60+0.0%4.9889 of 5 stars2.75$1,011.61 29.8%20Positive News4.41%ABTAbbott Laboratories$133.70-0.3%4.8981 of 5 stars2.76$142.61 6.7%21Trending News4.41%ABTAbbott Laboratories$133.70-0.3%4.8981 of 5 stars2.76$142.61 6.7%21Trending News4.06%RHHBYRoche$40.44-1.7%N/A2.5774.06%RHHBYRoche$40.44-1.7%N/A2.5773.61%UNHUnitedHealth Group$308.69+0.4%4.9978 of 5 stars2.60$415.57 34.6%25Trending NewsOptions Volume3.61%UNHUnitedHealth Group$308.69+0.4%4.9978 of 5 stars2.60$415.57 34.6%25Trending NewsOptions Volume3.39%BBIOBridgeBio Pharma$43.71+2.0%4.704 of 5 stars2.93$58.85 34.6%14News CoverageAnalyst ForecastInsider TradeAnalyst Revision3.39%BBIOBridgeBio Pharma$43.71+2.0%4.704 of 5 stars2.93$58.85 34.6%14News CoverageAnalyst ForecastInsider TradeAnalyst Revision3.17%BSXBoston Scientific$104.30+0.6%4.6075 of 5 stars3.13$116.09 11.3%24Trending NewsInsider Trade3.17%BSXBoston Scientific$104.30+0.6%4.6075 of 5 stars3.13$116.09 11.3%24Trending NewsInsider Trade3.11%VRTXVertex Pharmaceuticals$454.64-0.5%4.673 of 5 stars2.54$511.62 12.5%28Positive News3.11%VRTXVertex Pharmaceuticals$454.64-0.5%4.673 of 5 stars2.54$511.62 12.5%28Positive News3.03%GILDGilead Sciences$111.28-0.2%4.8478 of 5 stars2.78$110.55 -0.7%27Positive NewsInsider Trade3.03%GILDGilead Sciences$111.28-0.2%4.8478 of 5 stars2.78$110.55 -0.7%27Positive NewsInsider Trade2.89%MDTMedtronic$88.50+0.2%4.8984 of 5 stars2.63$97.87 10.6%19Trending NewsAnalyst Upgrade2.89%MDTMedtronic$88.50+0.2%4.8984 of 5 stars2.63$97.87 10.6%19Trending NewsAnalyst Upgrade2.70%CRNXCrinetics Pharmaceuticals$29.88+1.5%3.5829 of 5 stars2.90$71.75 140.2%102.70%CRNXCrinetics Pharmaceuticals$29.88+1.5%3.5829 of 5 stars2.90$71.75 140.2%102.49%AMGNAmgen$298.25+0.5%4.4545 of 5 stars2.35$307.82 3.2%23Positive News2.49%AMGNAmgen$298.25+0.5%4.4545 of 5 stars2.35$307.82 3.2%23Positive News2.49%TMOThermo Fisher Scientific$428.25+0.1%4.9948 of 5 stars2.80$604.05 41.1%20Positive News2.49%TMOThermo Fisher Scientific$428.25+0.1%4.9948 of 5 stars2.80$604.05 41.1%20Positive News2.40%MRKMerck & Co., Inc.$80.97-1.7%4.9963 of 5 stars2.43$109.19 34.8%21Positive News2.40%MRKMerck & Co., Inc.$80.97-1.7%4.9963 of 5 stars2.43$109.19 34.8%21Positive News2.18%ABBVAbbVie$189.50-0.7%4.9144 of 5 stars2.81$211.29 11.5%27Trending NewsAnalyst Revision2.18%ABBVAbbVie$189.50-0.7%4.9144 of 5 stars2.81$211.29 11.5%27Trending NewsAnalyst Revision2.11%BMYBristol Myers Squibb$47.02+0.0%4.9237 of 5 stars2.32$58.00 23.4%222.11%BMYBristol Myers Squibb$47.02+0.0%4.9237 of 5 stars2.32$58.00 23.4%222.04%PODDInsulet$301.14-0.2%4.1196 of 5 stars2.83$321.00 6.6%182.04%PODDInsulet$301.14-0.2%4.1196 of 5 stars2.83$321.00 6.6%182.04%EWEdwards Lifesciences$76.77-0.3%4.3539 of 5 stars2.40$80.20 4.5%25Positive News2.04%EWEdwards Lifesciences$76.77-0.3%4.3539 of 5 stars2.40$80.20 4.5%25Positive News1.98%DHRDanaher$203.08+0.3%4.883 of 5 stars2.80$248.61 22.4%20Positive News1.98%DHRDanaher$203.08+0.3%4.883 of 5 stars2.80$248.61 22.4%20Positive News1.89%MCKMcKesson$719.30+2.0%4.7165 of 5 stars2.86$696.42 -3.2%14Positive NewsAnalyst Revision1.89%MCKMcKesson$719.30+2.0%4.7165 of 5 stars2.86$696.42 -3.2%14Positive NewsAnalyst Revision1.89%REGNRegeneron Pharmaceuticals$545.00-0.5%4.9519 of 5 stars2.80$813.57 49.3%25Trending NewsAnalyst Downgrade1.89%REGNRegeneron Pharmaceuticals$545.00-0.5%4.9519 of 5 stars2.80$813.57 49.3%25Trending NewsAnalyst Downgrade1.89%ALNYAlnylam Pharmaceuticals$331.94+0.7%4.3087 of 5 stars2.79$340.00 2.4%24Analyst Forecast1.89%ALNYAlnylam Pharmaceuticals$331.94+0.7%4.3087 of 5 stars2.79$340.00 2.4%24Analyst Forecast1.49%CYTKCytokinetics$33.90-1.3%4.3186 of 5 stars2.93$70.92 109.2%15Positive News1.49%CYTKCytokinetics$33.90-1.3%4.3186 of 5 stars2.93$70.92 109.2%15Positive News1.41%DXCMDexCom$82.73-1.0%4.9005 of 5 stars2.95$98.50 19.1%22Positive NewsInsider Trade1.41%DXCMDexCom$82.73-1.0%4.9005 of 5 stars2.95$98.50 19.1%22Positive NewsInsider Trade1.32%IONSIonis Pharmaceuticals$42.98-1.4%4.6113 of 5 stars2.78$58.25 35.5%18News CoverageAnalyst Upgrade1.32%IONSIonis Pharmaceuticals$42.98-1.4%4.6113 of 5 stars2.78$58.25 35.5%18News CoverageAnalyst Upgrade1.30%ASNDAscendis Pharma A/S$174.07+0.6%3.5656 of 5 stars3.00$220.67 26.8%15Analyst Forecast1.30%ASNDAscendis Pharma A/S$174.07+0.6%3.5656 of 5 stars3.00$220.67 26.8%15Analyst Forecast1.22%MASIMasimo$167.67-2.1%4.2195 of 5 stars2.83$191.60 14.3%61.22%MASIMasimo$167.67-2.1%4.2195 of 5 stars2.83$191.60 14.3%61.07%ARWRArrowhead Pharmaceuticals$16.78-0.7%3.9262 of 5 stars2.75$43.71 160.5%81.07%ARWRArrowhead Pharmaceuticals$16.78-0.7%3.9262 of 5 stars2.75$43.71 160.5%81.05%VKTXViking Therapeutics$28.16+1.6%4.1784 of 5 stars3.00$87.15 209.5%141.05%VKTXViking Therapeutics$28.16+1.6%4.1784 of 5 stars3.00$87.15 209.5%141.02%AKROAkero Therapeutics$52.01+0.3%3.6442 of 5 stars3.00$82.50 58.6%61.02%AKROAkero Therapeutics$52.01+0.3%3.6442 of 5 stars3.00$82.50 58.6%61.00%MDGLMadrigal Pharmaceuticals$298.49-0.6%3.9865 of 5 stars2.89$420.63 40.9%91.00%MDGLMadrigal Pharmaceuticals$298.49-0.6%3.9865 of 5 stars2.89$420.63 40.9%90.95%GPCRStructure Therapeutics$20.62+0.9%2.735 of 5 stars3.00$76.17 269.4%7Positive News0.95%GPCRStructure Therapeutics$20.62+0.9%2.735 of 5 stars3.00$76.17 269.4%7Positive News0.91%MIRMMirum Pharmaceuticals$49.93+1.7%3.4283 of 5 stars3.13$65.50 31.2%80.91%MIRMMirum Pharmaceuticals$49.93+1.7%3.4283 of 5 stars3.13$65.50 31.2%80.86%INSMInsmed$98.50+0.3%4.5855 of 5 stars3.00$106.80 8.4%17Positive News0.86%INSMInsmed$98.50+0.3%4.5855 of 5 stars3.00$106.80 8.4%17Positive News0.83%WSTWest Pharmaceutical Services$221.75+0.2%4.7586 of 5 stars2.89$320.00 44.3%9Trending News0.83%WSTWest Pharmaceutical Services$221.75+0.2%4.7586 of 5 stars2.89$320.00 44.3%9Trending News0.64%SRRKScholar Rock$35.35-0.6%3.8698 of 5 stars3.14$42.67 20.7%70.64%SRRKScholar Rock$35.35-0.6%3.8698 of 5 stars3.14$42.67 20.7%70.35%MTSRMetsera$29.45+2.0%N/A3.00$55.00 86.8%50.35%MTSRMetsera$29.45+2.0%N/A3.00$55.00 86.8%50.32%MREOMereo BioPharma Group$2.88+0.2%1.9449 of 5 stars3.20$7.60 164.3%50.32%MREOMereo BioPharma Group$2.88+0.2%1.9449 of 5 stars3.20$7.60 164.3%50.26%NTLAIntellia Therapeutics$10.72-0.1%4.6493 of 5 stars2.65$33.37 211.4%200.26%NTLAIntellia Therapeutics$10.72-0.1%4.6493 of 5 stars2.65$33.37 211.4%200.18%RCKTRocket Pharmaceuticals$2.90+0.6%4.8857 of 5 stars2.41$18.60 542.3%17Trending News0.18%RCKTRocket Pharmaceuticals$2.90+0.6%4.8857 of 5 stars2.41$18.60 542.3%17Trending News This page (NASDAQ:HRTS) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And th...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Heart & Health ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Heart & Health ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HRTS Stock Alerts